Insulin glargine U-300 Max, Insulin glargine U-300
- Manufacturer
- Sanofi
- ICD-10 indication
- E11.9
Affordability Check
How much will you actually pay for Insulin glargine U-300 Max, Insulin glargine U-300?
In 30 seconds, see every legitimate way to afford Insulin glargine U-300 Max, Insulin glargine U-300 — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.
About Insulin glargine U-300 Max, Insulin glargine U-300
What is this medication?
Insulin glargine U-300 is a long-acting basal insulin used to improve blood sugar control in adults and pediatric patients six years of age and older with diabetes mellitus. This medication works by mimicking the body’s natural process of releasing a low level of insulin throughout the day and night. By providing a steady supply of insulin for twenty-four hours or more, it helps keep glucose levels stable between meals and during sleep.
This specific formulation is highly concentrated, containing three hundred units of insulin per milliliter, which allows for a smaller volume of liquid to be injected compared to standard strength insulins. It is typically administered once daily as a subcutaneous injection using a prefilled pen device. The Max version of the pen is specifically designed to deliver larger doses of this concentrated insulin in a single injection, making it an efficient option for patients who require higher daily amounts of insulin to manage their condition effectively.
Copay & patient assistance
- Patient Copay Amount:
- Insulins (Admelog, Apidra, Lantus, Toujeo, etc.): $35 per 30-day supply.
- Soliqua: As little as $35 per 30-day supply for commercially insured patients; as little as $99 per pack for cash-paying/uninsured patients.
- Multaq: As low as $0 per 30-day supply for commercially insured patients; up to $150 off per fill for cash-paying/uninsured patients.
- Maximum Annual Benefit Limit:
- Insulins: Not Publicly Available.
- Soliqua: Maximum savings of $365 per pack, up to two packs per 30-day supply.
- Multaq: Maximum savings of $760 per fill.
- Core Eligibility Restrictions:
- Offer not valid for prescriptions covered by or submitted for reimbursement under Medicare, Medicaid, VA, DOD, TRICARE, or similar federal or state programs.
- Must have commercial insurance or be uninsured (depending on the specific program selected).
- Cash-paying/uninsured patients using these programs may not submit claims for reimbursement to any third-party payor or seek to have costs count toward deductibles, TrOOP, or MOOP.
- Residents of certain states may be ineligible where prohibited by law.
- RxBIN, PCN, and Group numbers: Not Publicly Available.
External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.
Compare pricing elsewhere
RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.
Cost Plus Drug Company
Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for Insulin glargine U-300 Max, Insulin glargine U-300.
Browse Cost Plus medications →
GoodRx
Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.
Lookup Insulin glargine U-300 Max, Insulin glargine U-300 →
NeedyMeds
Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.
Search for Insulin glargine U-300 Max, Insulin glargine U-300 →
RxAssist
PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.
Search PAPs →
We deep-link because transparency helps patients. None of these partners pay RxCopays.
Conditions we've indexed resources for
Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.
Prior authorization & coverage
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | Yes | — | — |
Related drugs
ORLISTAT
Treats same condition · orlistat
Lopid
Treats same condition · gemfibrozil
DESMODA
Treats same condition · Desmopressin Acetate Oral Solution
Tricor
Treats same condition · Fenofibrate
olmesartan medoxomil-hydrochlorothiazide
Treats same condition · olmesartan medoxomil-hydrochlorothiazide
Glumetza
Treats same condition · metformin hydrochloride
Epaned
Treats same condition · enalapril maleate
DAPAGLIFLOZIN
Treats same condition · DAPAGLIFLOZIN
Exforge HCT
Treats same condition · amlodipine valsartan and hydrochlorothiazide
Alogliptin and Pioglitazone
Treats same condition · alogliptin and pioglitazone
How this page is sourced
- Drug identity verified against openFDA NDC Directory.
- Label text (when shown) originates from NLM DailyMed.
- Copay and assistance URLs verified periodically; if you hit a broken link, tell us.